POS-290 MORTALITY IN COVID-19 PATIENTS WITH CKD WITH AND WITHOUT KIDNEY REPLACEMENT THERAPY IN WESTERN MEXICO

Alejandra Rivera(Universidad de Guadalajara), Armando Aguilar(Universidad de Guadalajara), K. Rios(Universidad de Guadalajara), Yerimar Villegas(Universidad de Guadalajara), Madona Elias(Universidad de Guadalajara), A. Rico(Universidad de Guadalajara), C. Romo(Universidad de Guadalajara), Maydelín Miguel Morales(Universidad de Guadalajara), M. Valdez(Universidad de Guadalajara), L. Ruben(Universidad de Guadalajara), J. Gutierrez(Universidad de Guadalajara), Ricardo Parra(Universidad de Guadalajara), Jesus Topete(Universidad de Guadalajara), O. Sanchez(Universidad de Guadalajara)
Kidney International Reports
February 1, 2022
10.1016/j.ekir.2022.01.310
Cited by 0Open Access
Full Text

Abstract

COVID-19 is a new disease of pandemic proportions. Currently, there are no reports on clinical outcomes in patients with CKD with and without KRT in the Mexican population. Our aim was to describe the clinical outcomes in patients with CKD.

Related Papers

No related papers found

Powered by citation graph analysis